CLSI., 2013. Performance Standards for Antimicrobial Susceptibility Testing. 30th Edn., Clinical Laboratory Standards Institute, USA, ISBN-15: 978-68440-066-9, Pages: 332.
Walsh, T.R., M.A. Toleman, L. Poirel and P. Nordmann, 2005. Metallo-β-lactamases: The quiet before the storm? Clin. Microbiol. Rev., 18: 306-325.
Lee, K., Y.S. Lim, D. Yong, J.H. Yum and Y. Chong, 2003. Evaluation of the hodge test and the imipenem-edta double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol., 41: 4623-4629.
Yong, D., K. Lee, J.H. Yum, H.B. Shin, G.M. Rossolini and Y. Chong, 2002. Imipenem-edta disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol., 40: 3798-3801.
Varaiya, A., M. Kulkarni, P. Bhalekar and J. Dogra, 2008. Incidence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in diabetes and cancer patients. Indian J. Pathol. Microbiol., 51: 200-203.
Payne, D.J., 1993. Metallo-β-lactamases: New therapeutic challenge. J. Med. Microbiol., 39: 93-99.
Bush, K., 1999. beta-lactamases of increasing clinical importance. Curr. Pharm. Des., 5: 839-845.